comprehensive -WSS

comprehensive

author：fashion 2025-09-29 21:20:49 - browse：89132

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Hilary expected to bring catastrophic, life

Wikipedia

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

Four alarming medical procedures we’re glad history forgot

Gut bacteria may contribute to kidney autoimmunity, study finds

Multiple sclerosis has subtypes with different best treatments: study

The pain doctors face in trying to build their families

UnitedHealth, in a surprise, takes aim at Steward’s physician group

knowledge

comprehensive

entertainment

Sports medicine is finally prioritizing gender equality

UnitedHealth, in a surprise, takes aim at Steward’s physician group

At least 13 dead in Texas as scorching temps continue

Trial using CRISPR to edit HIV out of cells disappoints

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New details revealed about Purdue's marketing of OxyContin

The cancer drug shortage isn’t new — and neither are the solutions

Hilary expected to bring catastrophic, life

Hollywood unions extend contract negotiations for actors

Young boy dies in trial for Pfizer Duchenne gene therapy

entertainment

Four alarming medical procedures we’re glad history forgot

Cancer drug shortages' outsize impact on ovarian cancer patients

Researchers test human milk's ability to repair gut microbiome

Beware the threat of staffing cuts at the CDC

Young boy dies in trial for Pfizer Duchenne gene therapy

Medicare Advantage 2025 payments will dip, Biden administration says

hotspot

Wikipedia

entertainment

focus